اكتشف أفضل عيادات وتكاليف العلاج الخزعة في أنقرة 2024

Dr. Bilal Ergul, MD, is a pioneering force in the field of gastroenterology.  His innovative treatment protocols have transformed the lives of many patients, including a remarkable case where he successfully treated a patient with a Peroral Endoscopic Myotomy (POEM) surgery.Dr. Bilal Ergul, often says, ‘Healing is more than treating a condition; it’s about restoring hope and improving lives.’ This philosophy is evident in every aspect of his work, making his and his team truly inspirational figure in the medical community."He has authored around 100 publications in different academic topics

أدت خبرة البروفيسورة الدكتورة آيدان بيري في الجراحات الروبوتية في مجال أمراض النساء والتوليد إلى الاعتراف بها كـ "خبيرة في الجراحة الروبوتية". تشمل إنجازاتها الأكاديمية عملها كأستاذة مشاركة وأستاذة متفرغة. أكملت تعليمها الطبي في كلية الطب بجامعة أنقرة عام 1987، وتخصصت في طب النساء والتوليد عام 1992. الجوائز جراحة روبوتية خبيرة التدرج الوظيفي عملت في مستشفى أنقرة للولادة ومستشفى غازي. أسس مستشفى أنقرة كورو في عام 2010. عمل أستاذاً مساعداً في قسم أمراض النساء والتوليد في كلية الطب بجامعة غازي. أصبح أستاذاً مشاركاً في عام 2006. عُيّن أستاذاً متفرغاً في عام 2011.

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023. His medical interests include: Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic) Acute Leukemia Chronic Leukemia Treatments Hodgkin Lymphoma Non-Hodgkin Lymphoma Treatments Multiple Myeloma Treatments, MDS Aplastic Anemia ITP TTP Treatments Hypercoagulability Hereditary Thrombophilia Treatments Therapeutic Apheresis Photopheresis Geriatric Hematology Diseases.